|
Code
|
88831
|
|
MA number
|
EU/1/00/170/002
|
|
Product Form:
|
plv fol 1x7,5 mg (liek.skl.inj.)+1x5 ml solv.(amp.skl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Sanofi Winthrop Industrie, France
|
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
|
ATC:
|
| V |
VARIOUS |
| V03 |
ALL OTHER THERAPEUTIC PRODUCTS |
| V03A |
ALL OTHER THERAPEUTIC PRODUCTS |
| V03AF |
Detoxifying agents for antineoplastic treatment |
| V03AF07 |
Rasburicase |
|
|
Shelf life:
|
36 |
|
Container:
|
glass container
|
|
Route of admin.:
|
Intravenous use
|
European Medicines Agency's database
